Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT02162342
Other study ID # Upper_Extremety- HMO-CTIL
Secondary ID
Status Enrolling by invitation
Phase N/A
First received June 11, 2014
Last updated April 20, 2016
Start date July 2014

Study information

Verified date April 2016
Source Hadassah Medical Organization
Contact n/a
Is FDA regulated No
Health authority Israel: Ministry of Health - Director General
Study type Observational

Clinical Trial Summary

The subjet is sitting on a chair and in front of him an adjustable (height) table with a glass of water. 17 passive reflective markers are placed on his upper extremities and torso. The subject is requested to reach the glass (once with the right hand and then with the left hand) and bring it to the mouth and drink. Then the subject put the glass back at the starting position. This is performed twice for each hand. In the second part, the same trial is repeated but muscle activity is recorded with surface electromyography.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 0
Est. completion date
Est. primary completion date July 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- motor impairment following stroke, multiple sclerosis, cerebral palsy, traumatic brain injury, spina bifida, poliomyelitis, neuropathy

- Able to understand and sign an informed consent form independently.

Exclusion Criteria:

- Unable to hold or lift a glass

- pregnant women

Study Design

Observational Model: Case Control


Related Conditions & MeSH terms

  • Diagnosis and Follow up on Upper Extremity Interventions

Intervention

Other:
Rehabilitative treatment
Surgical intervention, orthotics or injections of muscle/nerve medications as prescribed by the treating physician and unrelated to the study.

Locations

Country Name City State
Israel Hadassah Medical Organization Jerusalem

Sponsors (1)

Lead Sponsor Collaborator
Hadassah Medical Organization

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary joint angle 2 years No